Pacira | PCRX - Umsatzerlöse





Der Umsatz Veränderung Datum
Assertio Holdings USD 29.2M 1.92M 2024-09
Astellas Pharma JPY 537.93B 33.28B 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Cara Therapeutics USD 2.57M 1.11M 2025-03
Coherus Biosciences USD 12.75M 1.18M 2025-12
Heron Therapeutics USD 40.59M 2.38M 2025-12
Ironwood Pharmaceuticals USD 106.51M 58.8M 2026-03
J&J USD 24.1B 500M 2026-03
Ligand Pharmaceuticals USD 51.72M 7.94M 2026-03
Nektar Therapeutics USD 21.81M 2.32M 2025-12
Novo Nordisk DKK 96.82B 17.68B 2026-03
Pacira USD 177M 19.87M 2026-03
Perrigo USD 969M 141M 2026-03
Pfizer USD 14.5B 3.08B 2026-03
Supernus Pharmaceuticals USD 207.71M 3.89M 2026-03
Teva Pharmaceutical Industries USD 11.77B 2.86B 2026-03
Xeris Pharmaceuticals USD 83.13M 2.68M 2026-03
Xoma USD 25K 5M 2024-09
Zoetis USD 2.3B 100M 2026-03